RE:RE:RE:RE:RE:RE:Exciting time
LGC Capital Raises $3 Million to Fund Global Medical Cannabis Expansion Plans Canada NewsWire MONTREAL, Sept. 5, 2017 MONTREAL,Sept. 5, 2017/CNW/ -LGC Capital Ltd. (TSXV: QBA)("LGC" or "LGC Capital)is pleased to announce that the subscription agreements received to date totals$3.0 millionfor its private placement of a maximum of 30,000,000 units, which has conditional approval from the TSX Venture Exchange, at a price of$0.10per unit, for maximum gross proceeds to LGC of$3.0 million. LGC has now received additional signed subscription agreements and subscription funds for a total aggregate amount of$3,000,000, which represents 30,000,000 units, of which senior management and directors are contributing$477,636. Due to the long weekend LGC announces that the TSX Venture Exchange has setFriday, September 8, 2017as the deadline for closing of the private placement. John McMullen, LGC's CEO, comments: "On behalf of LGC I would like to personally thank our new investors and the company's insiders for investing in LGC's global strategy. This money will rapidly advance our legal medical cannabis initiatives not only in southernAfricabut will and also the Company to pursue new investment initiatives in the Asian Pacific region where we see accretive legal cannabis opportunities." Each of the units will be comprised of one common share and one common share purchase warrant; each warrant will entitle its holder to acquire one additional LGC common share at a price of$0.15for a period of one year from the closing date. In the event that the closing price of LGC's common shares on the TSX Venture Exchange is at least$0.20for a period of not less than 20 consecutive trading days, the warrants will expire, at the sole discretion of LGC, on the 30thday after the date on which LGC sends a notice in prescribed form to the holders of the warrants.